ABSTRACT
Objective:
The aim of this study is to investigate whether the expression of GLUT-1, COX-2, MMP-19, p53 and Elastic-van Gieson (EVG) protein are significant in the differential diagnosis of squamous cell carcinoma (SCC) and keratoacanthoma (KA).
Methods:
A total of 156 cases, 105 of whom were SCC and 51 were KA, which were diagnosed between 2001 and 2011 years in Cumhuriyet University Department of Pathology, were examined histochemically by EVG and immunohistochemically by GLUT-1, COX-2, MMP-19 and p53.
Results:
Expression values of GLUT-1, COX-2, MMP-19, p53, and EVG were found to be statistically significant in the differential diagnosis of SCC and KA (p<0.05). The highest staining was seen with GLUT-1 (54%) and minimal staining with COX-2 (9%) among the tumor groups. The SCC and KA cases in the study were 60% and 41% immunoreactive with GLUT-1; 13% and 2% immunoreactive with COX-2; 24% and 0% immunoreactive with MMP-19; 31% and 16% immunoreactive with p53; 20% and 56.9% historeactive with EVG, respectively.
Conclusion:
All markers used in our study were found to be useful in the differential diagnosis of SCC and KA, but, we think that further molecular and genetic studies will facilitate the correct diagnosis.
References
1
Parekh V, Seykora JT. Cutaneous Squamous Cell Carcinoma. Clin Lab Med 2017;37:503-25.
2
Kumar V, Abbas AK, Fausto N, et al. Robbins and Cotran Pathologic Basic of Disease, 8th ed., Chapter 25: The Skin. Saunders Elsevier, Philadelphia 2010;p1165-204.
3
Singh A, Willems E, Singh A, et al. Ultraviolet radiation-induced tumor necrosis factor alpha, which is linked to the development of cutaneous SCC, modulates differential epidermal microRNAs expression. Oncotarget 2016;7:17945-56.
4
Ogita A, Ansai SI, Misago N, et al. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors. J Dermatol 2016;43:1321-31.
5
Yıldız E, Göze F. The Measurement of Nuclear DNA Content with Microspectrophotometry in Keratoacanthomas and Squamous Cell Carcinomas of the Skin. Tur J Neoplasia 2001;9:25-30.
6
Bostancı S, Saral S. Benign ve Premalign Tümörler (Cherry Anjioma, Sebase Hiperplazi, Seboreik Keratoz, Skin Tag, Aktinik Keilitis, Aktinik Keratoz, Lökoplaki, Keratoakantoma). Turkiye Klinikleri J Dermatol-Special Topics 2009;2:41-6.
7
LeBoit PE. Is keratoakanthoma a variant of squamous cell carcinoma? New insights into an old controversy soon? Am J Dermatopathol 1995;4:319-20.
8
Schwartz RA. Keratoacanthoma: a clinical-pathologic enigma. Dermatol Surg 2004;30:326-33.
9
Karaa A, Khachemoune A. Keratoakanthoma: a tumor in search of classification. Int J Dermatol 2007;46:671-8.
10
Brustmann H. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study. Gynecol Oncol 2005;98:396-402.
11
LeBoit P, Burg G, Weedon D, Sarasin A. World Health Organizatiom Classification of Tumors of the Skin Tumors, Chapter 1: Keratinocytic Tumors. IARCH pres, Lyon, 2005;p9-48.
12
Otley CC. Non-melonoma skin cancer: past, present, and future. Curr Probl Dermatol 2001;13:109-13.
13
Elder D, Elenitsas R, Jaworsky C, Johnson B. Lever’s Histopathology of the Skin, 8 th. Ed., Chapter 30: Tumors and Cysts of the Epidermis, Lippincott - Raven, Philadelphia, 1997;p685-746.
14
Farmer ER, Hood AF. Pathology of the Skin, 1th ed., Chapter 44: Malign Tumors of the Epidermis. Appleton & Lange, United States of America, 1990;p568-95.
15
Park HR, Min SK, Cho HD, et al. Expression profiles of p63, p53, survivin, and hTERT in skin tumors. J Cutan Pathol 2004;31:544-9.
16
İşçimen A, Kutlubay Z. Keratoakantoma Olgularında Psödomalign - Psödobenign İkilemi. Dermatoz 2010;1:153-62.
17
Busom KJ. Dermatopathology, 1th ed., Chapter 17: Epidermal Tumors. Saunders Elsevier, U S A, 2010
18
McCombe D, MacGill K, Ainslie J, et al. Squamous cell carcinoma of the lip: a retrospective rewiew of the Peter MacCallum Cancer Institue experience 1979-88. Aust NZ J Surg 2000;70: 358-61.
19
Göze F. Derinin Keratoakantom ve Yassı Hücreli Karsinomlarının Proliferasyon Kinetiklerinin Çift Parametre (AgNOR ve Ki-67) ile Karşılaştırılması. Tur J Neoplasia 1994;2:87-96.
20
Abdou AG, Eldien MM, Elsakka D. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas. Int J Surg Pathol 2015;23:447-53.
21
Mendes RA, Carvalho JFC, Waal I. An overview on the expression of cyclooxygenase-2 in tumors of the head and neck. Oral Oncol 2009;45:124-28.
22
Seleit I, Bakry OA, Al-Sharaky DR, et al. Evaluation of Hypoxia Inducible Factor-1α and Glucose Transporter-1 Expression in Non Melanoma Skin Cancer: An Immunohistochemical Study. J Clin Diagn Res 201711:EC09-EC16.
23
Stephenson TJ, Royds J, Silcooks PB, et al. Mutant p53 oncogen experession in kerathoacanthoma and squamous cell carcinoma. Br J Dermatol 1992;127:566-77.
24
Marutha Muthu AK, Cheah PL, Koh CC, et al. Cyclooxygenase-2 (COX2) expression in adenocarcinoma surpasses that of squamous cell carcinoma in the uterine cervix. Malays J Pathol 2017;39:251-5.
25
Dursun P, Yuce K, Usubutun A, et al. Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables. Int J Gynecol Cancer 2007;17:164-73.
26
Kim YB, Kim GE, Pyo HR, et al. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2004;60:822-9.
27
Sales KJ, Katz AA, Davis M, et al. Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 2001;86:2243-9.
28
Sano Y, Kogashiwa Y, Araki R, et al. Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis. Otolaryngol Head Neck Surg 2018;158:667-6q76.
29
Kuivanen TT, Jeskanen L, Kyllönen L, et al. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas. Modern Pathol 2006;19:1203-12.
30
Impola U, Toriseva M, Suomela S, et al. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 2003;103:709-16.
31
Drvar DL, Lipozenčić J, Mokos ZB, et al. Association of skin phototype and UV exposure with expression of HER receptors, Ki67 and p53 in patients with cutaneous squamous cell carcınoma. Acta Med Croatica 2015;69:431-8.
32
Suk JD, Park WS, Kim DK. Low rates of somatic p53 mutations in keratoacanthomas. J Dermatol Sci 2009;53:72-3.
33
Marinescu A, Stepan AE, Mărgăritescu C, et al. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions. Rom J Morphol Embryol 2016;57(Suppl 2):691-6.
34
McCombe D, MacGill K, Ainslie J, et al. Squamous cell carcinoma of the lip: a retrospective rewiew of the Peter MacCallum Cancer Institue experience 1979-88. Aust NZ J Surg 2000;70:358-61.